8th European Congress of Pharmacology (EPHAR)
July 5-9, 2020 Prague, Czech Republic For further information please visit the following page: https://www.ephar2020.org/
February 18, 2020
Third International Convention IMMUNOPHARMACOLOGY–VACCIPHARMA 2020
June 9-13, 2020 and June 14-18, 2020Varadero beach, Cuba.This Convention is the fusion of the 5th International Congress on Immunopharmacology (IMMUNOPHARMACOLOGY 2020) to be held in June 9-13, 2020 and the 5th International Congress on Pharmacology of Vaccines (VACCIPHARMA 2020), to be held in June
February 18, 2020
EAACI Annual Meeting
June 6-10, 2020London, UK For more information please visit: https://www.eaaci.org/eaaci-congresses/eaaci-2020
February 18, 2020
World Allergy Organization (WAO) International Scientific Conference (WISC) 2020
April 23-25, 2020Rome, Italy For more information, please visit: https://www.worldallergy.org/wisc2020
February 18, 2020
SFI 2019 – 12 to 14 November 2019 – Nantes events Center, Nantes, France
Annual meeting from the French Society Immunology on Nov 10-12 2019 in Nantes, France. The French “Mast Cell & Basophil Club” will have a dedicated session during the meeting with keynote speaker Dr. Adrian Piliponsky (Seattle Children’s Research Institute). For more info, program and registration,
October 14, 2019
Mast Cell Cytonemes as a Defense Mechanism against Coxiella burnetii
Summary Mast cells (MCs) are critical mediators of inflammation; however, their microbicidal activity against invading pathogens remains largely unknown. Here, we describe a nonpreviously reported antibacterial mechanism used by MCs against Coxiella burnetii, the agent of Q fever. We show that C. burnetii interaction with
April 26, 2019
Progenitor mast cells and tryptase in Q fever
Summary Q fever is an infectious disease due to Coxiella burnetii. Following a primary-infection, C. burnetii may persist in some patients, leading to endocarditis and vascular infections. Mast cells (MCs), known for their role in allergic diseases, innate immunity and cardiac function, are produced by
March 14, 2019
Fevipiprant, a DP2 receptor antagonist, inhibits eosinophil migration towards mast cells
Summary Fevipiprant, a DP2 receptor antagonist, inhibits eosinophil migration towards mast cells Citation Fevipiprant, a DP2 receptor antagonist, inhibits eosinophil migration towards mast cells. Shamri R, Dubois G, Erpenbeck VJ, Mankuta D, Sandham DA, Levi-Schaffer F. Clin Exp Allergy. 2019 Feb;49(2):255-257. doi: 10.1111/cea.13304. Epub 2018
October 28, 2018
Functional Inhibitory Siglec-6 Is Upregulated in Human Colorectal Cancer-Associated Mast Cells
Summary Mast cells (MC) accumulate in colorectal cancer (CRC) and the relationship between MC density and cancer progression has been well recognized. Citation Yu Y, Blokhuis BRJ, Diks MAP, Keshavarzian A, Garssen J and Redegeld FA (2018) Functional Inhibitory Siglec-6 Is Upregulated in Human Colorectal
September 20, 2018
Isolation of Human Placental Mast Cells
Summary Mast cells have been identified as resident cells of human placental tissue by immunohistological procedures, suggesting that they may play a role in pregnancy. Citation Mezouar, Soraya & Ben Amara, Amira & Vitte, Joana & Mege, Jean‐Louis. (2018). Isolation of Human Placental Mast Cells.
August 31, 2018
Looking for other posts?
Categories
Archives
- November 2023
- August 2023
- June 2023
- May 2023
- October 2022
- September 2022
- August 2022
- July 2022
- March 2022
- January 2022
- September 2021
- August 2021
- June 2021
- March 2021
- February 2021
- January 2021
- December 2020
- September 2020
- August 2020
- July 2020
- April 2020
- February 2020
- October 2019
- April 2019
- March 2019
- October 2018
- September 2018
- August 2018
- June 2018
- March 2018
- February 2018
- October 2017
- May 2017
- May 2015
- March 2015
- December 2013
- November 2013
- October 2013
- September 2013
- February 2013
- December 2012
- November 2012
- October 2012
- September 2012